GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EC Healthcare (HKSE:02138) » Definitions » ROE %

EC Healthcare (HKSE:02138) ROE % : 0.71% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is EC Healthcare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. EC Healthcare's annualized net income for the quarter that ended in Sep. 2023 was HK$13 Mil. EC Healthcare's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was HK$1,867 Mil. Therefore, EC Healthcare's annualized ROE % for the quarter that ended in Sep. 2023 was 0.71%.

The historical rank and industry rank for EC Healthcare's ROE % or its related term are showing as below:

HKSE:02138' s ROE % Range Over the Past 10 Years
Min: -0.2   Med: 28.03   Max: 4725.41
Current: -0.2

During the past 9 years, EC Healthcare's highest ROE % was 4,725.41%. The lowest was -0.20%. And the median was 28.03%.

HKSE:02138's ROE % is ranked worse than
62.62% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.395 vs HKSE:02138: -0.20

EC Healthcare ROE % Historical Data

The historical data trend for EC Healthcare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EC Healthcare ROE % Chart

EC Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROE %
Get a 7-Day Free Trial Premium Member Only 38.77 28.03 16.98 12.54 3.73

EC Healthcare Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.98 3.74 8.37 -1.09 0.71

Competitive Comparison of EC Healthcare's ROE %

For the Medical Care Facilities subindustry, EC Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EC Healthcare's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's ROE % distribution charts can be found below:

* The bar in red indicates where EC Healthcare's ROE % falls into.



EC Healthcare ROE % Calculation

EC Healthcare's annualized ROE % for the fiscal year that ended in Mar. 2023 is calculated as

ROE %=Net Income (A: Mar. 2023 )/( (Total Stockholders Equity (A: Mar. 2022 )+Total Stockholders Equity (A: Mar. 2023 ))/ count )
=69.654/( (1881.254+1854.484)/ 2 )
=69.654/1867.869
=3.73 %

EC Healthcare's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Mar. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=13.302/( (1854.484+1879.924)/ 2 )
=13.302/1867.204
=0.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


EC Healthcare  (HKSE:02138) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=13.302/1867.204
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(13.302 / 4242.624)*(4242.624 / 5537.5465)*(5537.5465 / 1867.204)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.31 %*0.7662*2.9657
=ROA %*Equity Multiplier
=0.24 %*2.9657
=0.71 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=13.302/1867.204
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (13.302 / 70.564) * (70.564 / 196.314) * (196.314 / 4242.624) * (4242.624 / 5537.5465) * (5537.5465 / 1867.204)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.1885 * 0.3594 * 4.63 % * 0.7662 * 2.9657
=0.71 %

Note: The net income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


EC Healthcare ROE % Related Terms

Thank you for viewing the detailed overview of EC Healthcare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


EC Healthcare (HKSE:02138) Business Description

Traded in Other Exchanges
Address
8 Argyle Street, L50, Langham Place Office Tower, Mong Kok, Hong Kong, HKG
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare and beauty products. The group caters to its services through the operating segments of Medical which is the key revenue generator segment and Aesthetic medical, beauty and wellness, and Veterinary and others. Geographically, the group has a business presence in Hong Kong, Macau, and the PRC.
Executives
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Tang Chi Fai 2202 Interest of your spouse
Yau Ming Li 2101 Beneficial owner
Union Medical Care Holding Limited 2101 Beneficial owner

EC Healthcare (HKSE:02138) Headlines

No Headlines